You are here:Home-Chemical Inhibitors & Agonists-Cell Cycle/DNA Damage-Polo-like Kinase (PLK)-Poloxin
Poloxin

Chemical Structure : Poloxin

CAS No.: 321688-88-4

Poloxin

Catalog No.: PC-62393Not For Human Use, Lab Use Only.

Poloxin is the first reported PLK1 PBD inhibitor with IC50 of 6.4 uM, shows less potent inhibition for Plk2 PBD and Plk3 PBD.

Packing Price Stock Quantity
25 mg $88 In stock
50 mg $138 In stock
100 mg $218 In stock
200 mg Get quote

Bulk size, bulk discount!

E-mail: sales@probechem.com

Tech Support: tech@probechem.com

Purity & Documentation Purity: >98% (HPLC) Select Batch:

Biological Activity

Poloxin is the first reported PLK1 PBD inhibitor with IC50 of 6.4 uM, shows less potent inhibition for Plk2 PBD and Plk3 PBD.
Poloxin inhibits the function of the Plk1 PBD in vitro, and cause Plk1 mislocalization, chromosome congression defects, mitotic arrest, and apoptosis in HeLa cells.
Poloxin activates the spindle assembly checkpoint and inhibits tumor growth in xenograft mouse models.

Physicochemical Properties

M.Wt 297.354
Formula C18H19NO3
Appearance Solid
CAS No.
Storage
Solide Powder
-20 °C 12 Months; 4°C 6 Months
In Solvent
-80 °C 6 Months; -20°C 6 Months
Shipping
Solubility

10 mM in DMSO

Chemical Name/SMILES

2-Methyl-5-(1-methylethyl)-1-[O-(2-methylbenzoyl)oxime]-2,5-Cyclohexadiene-1,4-dione

References

1. Reindl W, et al. Chem Biol. 2008 May;15(5):459-66.

2. Scharow A, et al. ACS Chem Biol. 2015 Nov 20;10(11):2570-9.

3. Yuan J, et al. Am J Pathol. 2011 Oct;179(4):2091-9.

Copyright © 2022 probechem.com. All Rights Reserved. probechem Copyright

Contact Us sales@probechem.com

Bulk Inquiry

* Indicates a Required FieldYour information is safe with us.

  • *Product name:
  • *Applicant name:
  • *Email address:
  • *Organization name:
  • *Requested quantity:
  • *Country:
  • *Additional Information:

Get Quote

* Indicates a Required FieldYour information is safe with us.

  • *Product name:
  • *Applicant name:
  • *Email address:
  • *Organization name:
  • *Requested quantity:
  • *Country:
  • Additional Information: